Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Intercure Ltd. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 20 | 17 | −3 |
| Shares | 2.65M | 2.51M | −142.2K (−5.4%) |
| Value | $5.22M | $4.00M | −$1.22M (−23.4%) |
New holders (2)
Institutions that held Intercure Ltd. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Moore Capital Management, LP | 97,273 | $155.6K | 0.00% |
| Squarepoint Ops LLC | 11,434 | $18.3K | 0.00% |
Sold out (5)
Institutions that held Intercure Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Toroso Investments, LLC | 229,500 | $461.3K |
| Financial Network Wealth Advisors LLC | 1,000 | $2.01K |
| Citigroup Inc | 521 | $987 |
| UBS Group AG | 44 | $88 |
| Simplex Trading, LLC | 33 | $0 |